ValuEngine Weekly: Medical Stocks, SNAP Inc, Valuations, and More

EDITOR’S NOTE: We will be on a limited publication schedule later this month. Bulletins will be reduced the weeks of August 20-24 (we will publish M-W) and September 3-7 (we will publish W-F). There will be no bulletins the week of August 27-31. We will return to our normal publication schedule the week of September 10th.

This week, we provide top-five ranked VE data for our Medical Sector stocks. We take a look at our latest data on Snap Inc $SNAP and provide a free download link for our stock report on the company.

VALUATION WATCH: Overvalued stocks now make up 51.71% of our stocks assigned a valuation and 20.51% of those equities are calculated to be overvalued by 20% or more. Thirteen sectors are calculated to be overvalued.

ValuEngine Index Overview

Index Week Open Friday PM Change % Change YTD
DJIA 25437.43 25342.53 -94.9 -0.37% 2.47%
NASDAQ 7809.54 7864.72 55.18 0.71% 13.90%
RUSSELL 2000 1673.25 1693.53 20.28 1.21% 10.34%
S&P 500 2840.29 2839.34 -0.95 -0.03% 6.15%

ValuEngine Market Overview

Summary of VE Stock Universe
Stocks Undervalued 48.29%
Stocks Overvalued 51.71%
Stocks Undervalued by 20% 19.12%
Stocks Overvalued by 20% 20.51%

ValuEngine Sector Overview

Sector Change MTD YTD Valuation Last 12-MReturn P/E Ratio
Computer and Technology 0.10% 2.73% 8.69% 16.07% overvalued 26.77% 31.97
Aerospace -0.34% -1.19% 7.33% 14.47% overvalued 18.45% 26.69
Retail-Wholesale 0.20% 1.04% 6.51% 10.24% overvalued 26.68% 24.28
Medical 0.03% 0.40% 14.71% 10.22% overvalued 42.88% 30.18
Multi-Sector Conglomerates -0.26% -0.31% -1.52% 8.31% overvalued 7.47% 20.66
Business Services 0.05% 0.51% 10.53% 7.94% overvalued 22.91% 25.19
Consumer Discretionary 0.12% 0.96% 4.11% 5.99% overvalued 16.50% 26.58
Utilities 0.52% 1.20% -3.43% 4.62% overvalued -3.10% 20.01
Finance 0.02% 0.19% 2.53% 2.80% overvalued 8.01% 17.70
Consumer Staples -0.07% -0.78% -1.42% 2.70% overvalued 10.62% 24.53
Auto-Tires-Trucks 0.29% 0.88% -1.52% 1.29% overvalued 4.40% 12.76
Industrial Products 0.24% 0.57% 4.10% 1.07% overvalued 17.25% 25.35
Transportation 0.10% 0.16% -0.14% 0.25% overvalued 15.67% 18.94
Construction -0.05% -1.24% 0.77% 4.25% undervalued 15.99% 21.17
Basic Materials -0.36% -1.27% 3.62% 8.19% undervalued 2.56% 20.98
Oils-Energy 0.42% 0.19% 8.95% 11.82% undervalued 17.98% 25.31

 

Want to learn more about ValuEngine? Our methods? Our history?
Check out our video presentation HERE

 

Sector Talk–Medical

Below, we present the latest data on Medical stocks from our Professional Stock Analysis Service. Top- five lists are provided for each category.  We applied some basic liquidity criteria–share price greater than $3 and average daily volume in excess of 100k shares.

Top-Five Medical Stocks–Short-Term Forecast Returns

Ticker Name Mkt Price Valuation (%) Last 12-M Return (%)
IDRA IDERA PHARMACT 7.31 230.40% 301.65%
ABUS ARBUTUS BIOPH 9.8 128.85% 164.86%
FATE FATE THERAPEUTC 11.42 159.65% 276.90%
XENE XENON PHARMACT 12.1 117.54% 340.00%
ZGNX ZOGENIX INC 50.1 173.29% 370.42%

Top-Five Medical Stocks–Momentum

Ticker Name Mkt Price Valuation (%) Last 12-M Return (%)
MDGL MADRIGAL PHARMA 236.1 300.00% 1412.49%
MRTX MIRATI THERAPTC 58.65 155.20% 1147.87%
ECYT ENDOCYTE INC 16.29 124.20% 1106.67%
VKTX VIKING THERAPTC 9.89 117.49% 957.87%
CDNA CAREDX INC 14.97 77.24% 954.23%

Top-Five Medical Stocks–Composite Score

Ticker Name Mkt Price Valuation (%) Last 12-M Return (%)
NKTR NEKTAR THERAP 59.37 -0.74% 217.83%
BHC BAUSCH HEALTH 23.17 -19.76% 64.68%
THC TENET HEALTH 32.48 -3.22% 140.06%
ESRX EXPRESS SCRIPTS 81.82 0.39% 33.69%
ENDP ENDO INTL PLC 15.83 17.36% 99.37%

Top-Five Medical Stocks–Most Overvalued

Ticker Name Mkt Price Valuation (%) Last 12-M Return (%)
MDGL MADRIGAL PHARMA 236.1 300.00% 1412.49%
IMMU IMMUNOMEDICS 23.29 300.00% 184.02%
EIGR EIGER BIOPHARMA 9.85 300.00% 27.92%
LJPC LA JOLLA PHARMA 24.465 286.56% -23.09%
CASI CASI PHARMACEUT 7.3 246.84% 637.37%

 

 

Free Download for Readers

As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports

Snap Inc. (SNAP) provides technology and social media services. The Company’s principal product Snapchat, is a camera application that helps people to communicate through short videos and images. Snap Inc. is headquartered in Venice, California.

VALUENGINE RECOMMENDATION: ValuEngine continues its HOLD recommendation on SNAP INC for 2018-08-09. Based on the information we have gathered and our resulting research, we feel that SNAP INC has the probability to ROUGHLY MATCH average market performance for the next year. The company exhibits ATTRACTIVE Company Size but UNATTRACTIVE Sharpe Ratio.

You can download a free copy of detailed report on Snap Inc. (SNAP) from the link below.

Read our Complete Rating and Forecast Report HERE

ValuEngine Forecast
Target
Price*
Expected
Return
1-Month 12.34 0.24%
3-Month 12.67 2.94%
6-Month 12.84 4.34%
1-Year 12.66 2.84%
2-Year 13.37 8.65%
3-Year 13.12 6.60%
Valuation & Rankings
Valuation n/a Valuation Rank(?) n/a
1-M Forecast Return 0.24% 1-M Forecast Return Rank 68
12-M Return -9.22% Momentum Rank(?) 21
Sharpe Ratio -0.96 Sharpe Ratio Rank(?) 6
5-Y Avg Annual Return -44.18% 5-Y Avg Annual Rtn Rank 11
Volatility 45.88% Volatility Rank(?) 35
Expected EPS Growth 2.98% EPS Growth Rank(?) 23
Market Cap (billions) 8.15 Size Rank 86
Trailing P/E Ratio n/a Trailing P/E Rank(?) 17
Forward P/E Ratio n/a Forward P/E Ratio Rank n/a
PEG Ratio 3.69 PEG Ratio Rank 9
Price/Sales 8.99 Price/Sales Rank(?) 13
Market/Book 4.09 Market/Book Rank(?) 33
Beta -2.57 Beta Rank 98
Alpha 0.25 Alpha Rank 87

 

ValuEngine.com is an Independent Research Provider (IRP), producing buy/hold/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.
Contact ValuEngine at (321) 325-0519 or support@valuengine.com  
Visit www.ValuEngine.com for more information

 

ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuEngine’s award-winning stock research.
Contact ValuEngine Capital at info@valuenginecapital.com
Visit www.ValuEngineCapital.com for more information

 

Steve Hach
Senior Editor
ValuEngine.com